Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Organisation › Details

NorthSea Therapeutics B.V. (NST)

NorthSea Therapeutics B.V. (NST) is a biotech company focused on developing structurally engineered fatty acids (‘SEFAs’) for the treatment of inflammatory and liver diseases. NST licensed the rights to its lead compound icosabutate and a library of discovery- and pre-clinical-stage SEFAs from Pronova BioPharma Norge AS, who developed among others Omacor®, a blockbuster cardiovascular drug. Icosabutate has been found safe and effective in two prior phase II clinical studies for treatment of hypertriglyceridemia and is currently in clinical development for NASH, aiming to be phase IIb-ready by end 2018. NST is a private Dutch company, with employees in the Netherlands, the UK and Norway. *


Period Start 2017-12-12 established
Products Industry icosabutate
  Industry 2 drug development
Person Person Slootweg, Sander (Forbion Capital Partners 20111 Managing Partner before ABN AMRO Capital)
  Street 2-35 Gooimeer
  City 1411 DC Naarden
  Tel +31 (0) 35 699 30 00
    Address record changed: 2017-12-13
Basic data Employees n. a.
    * Document for �About Section�: NorthSea Therapeutics B.V.. (12/12/17). "Press Release: NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug". Naarden.
Record changed: 2020-01-08


Picture [LSE] – The Business Web Portal 650x65px

More documents for NorthSea Therapeutics B.V. (NST)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top